Could pregnancy checkups also screen for cancer genes?
NCT ID NCT07052266
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study explores whether offering genetic testing for inherited cancer risk (like BRCA1/2) during routine pregnancy or fertility care is practical and acceptable to patients. Researchers will enroll 550 people receiving prenatal or preconception care at Weill Cornell Medicine. The goal is to see how many complete both standard prenatal genetic screening and the optional cancer risk screening, and to understand if this approach could help catch cancer risks earlier, especially in underserved groups.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MyRisk Hereditary Cancer Test (genetic screening)
- What this could lead to
- If successful, this could show that offering cancer genetic testing during pregnancy or fertility care is practical and welcomed, potentially leading to earlier cancer detection and prevention in a broader population.
- What could go wrong
- This is an early feasibility study, not a treatment trial. It measures interest and completion rates, not health outcomes. Results may not apply to all populations or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY CANCER SYNDROMES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NewYork-Presbyterian Weill Cornell Medicine
NOT_YET_RECRUITINGBrooklyn, New York, 11215, United States
-
NewYork-Presbyterian Weill Cornell Medicine Queens
RECRUITINGQueens, New York, 11355, United States
-
Reproductive Medicine
RECRUITINGBrooklyn, New York, 11201, United States
-
Reproductive Medicine
RECRUITINGNew York, New York, 10021, United States
-
Weill Cornell Medicine
RECRUITINGNew York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital assistant aims to close gaps in hereditary cancer care
- Can a registry help more families get tested for cancer genes?
- New online tool aims to help families uncover hidden cancer risks
- New program aims to close cancer screening gaps for rural families
- New questionnaire aims to catch hidden cancer genes in children
- Can an app keep young people with cancer genes on track?